Mr. Foster has served as an executive at Trice for five years. Previously, he held several leadership roles with U.K. medical technology company Smith+Nephew, capping an eight-year tenure with a stint as the company’s vice president of U.S. sports medicine.
Xenocor adds orthopedic device CEO to its board of directors
Mark Foster, president and CEO of Malvern, Pa.-based orthopedic device company Trice Medical, is joining Salt Lake City-based surgical technology company Xenocor as a member on its board of directors, the company said Sept. 20.
Shared risk, shared data: What leaders say is really driving payer-provider alignment
Recommended Whitepaper